Modulating effects of WT1 on interferon-β-vitamin D association in MS

Area of Science:

• Neuroimmunology
• Genetics
• Endocrinology

Background:

• Interferon-beta (IFN-β) is a common treatment for multiple sclerosis (MS).
• Vitamin D levels are often altered in MS patients and may influence disease activity.
• The interplay between vitamin D, IFN-β, and genetic factors in MS is not fully understood.

Purpose of the Study:

• To investigate if genes in the vitamin D pathway modulate the relationship between 25-hydroxyvitamin D (25(OH)D) and IFN-β.
• To examine how IFN-β and sun exposure predict 25(OH)D levels.
• To assess the interaction between IFN-β and 25(OH)D in predicting relapse risk in MS patients.

Main Methods:

• Prospective cohort study of 169 MS participants with genotype data.
• Multilevel mixed-effects linear regression to evaluate gene-IFN-β and gene-IFN-β-sun interactions predicting 25(OH)D.
• Survival analysis to assess gene-IFN-β interactions with 25(OH)D in modulating relapse risk.

Main Results:

• Two single nucleotide polymorphisms (SNPs) in the WT1 gene (rs10767935 and rs5030244) significantly modified the association between IFN-β and 25(OH)D.
• Evidence suggested a difference in the sun exposure-IFN-β-25(OH)D association based on rs10767935 levels.
• No significant genetic modification was found for the interaction between IFN-β and 25(OH)D in predicting relapse risk.

Conclusions:

• Specific WT1 gene variants significantly alter the relationship between IFN-β and vitamin D levels in MS.
• WT1 variants may influence how IFN-β affects vitamin D metabolism in the context of MS.
• Further research is warranted to explore the role of WT1 in MS pathogenesis and treatment response.